245 PUBLICATIONS Published and submitted journal articles 1. F.R. Teunissen, T. Willigenburg, A.C. Tree, W.A. Hall, S.L. Choi, A. Choudhury, J.P. Christodouleas, J.C.J. de Boer, E.N. de Groot-van Breugel, L.G.W. Kerkmeijer, F.J. Pos, T.S. Schytte, D. Vesprini, H.M. Verkooijen, J.R.N. van der Voort van Zyp. Magnetic resonance guided adaptive radiotherapy for prostate cancer: the first results from the MOMENTUM study, an international registry for the evidence-based introduction of MR-guided adaptive radiotherapy. Practical Radiation Oncology (2022). In press. 2. T. Willigenburg, C. Zachiu, G.H. Bol, E.N. de Groot-van Breugel, J.J.W. Lagendijk, J.R.N. van der Voort van Zyp, B.W. Raaymakers, J.C.J. de Boer. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: a practical method to mitigate intrafraction motion. Radiotherapy and Oncology (2022). DOI: 10.1016/j.radonc.2022.09.004. 3. F.R. Teunissen, T. Willigenburg, R.P. Meijer, H.H.E. van Melick, H.M. Verkooijen, J.R.N. van der Voort van Zyp. The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating ‘trials within cohorts’ (TwiCs) for the evaluation of interventions for prostate cancer. World Journal of Urology (2022). DOI: 10.1007/s00345-022-04092-2. 4. T. Willigenburg, J.M. van der Velden, C. Zachiu, F.R. Teunissen, J.J.W. Lagendijk, B.W. Raaymakers, J.C.J. de Boer, J.R.N. van der Voort van Zyp. Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy. Radiotherapy and Oncology (2022). DOI: 10.1016/j.radonc.2022.04.022. 5. T. Willigenburg, C. Zachiu, J.J.W. Lagendijk, J.R.N. van der Voort van Zyp, J.C.J. de Boer, B.W. Raaymakers. Fast and accurate deformable contour propagation for intra-fraction adaptive magnetic resonance-guided prostate radiotherapy. Physics and Imaging in Radiation Oncology (2022). DOI: 10.1016/j.phro.2022.02.008. 6. D. den Boer, M.D. den Hartogh, A.N.T.J. Kotte, J.R.N. van der Voort van Zyp, J.L. Noteboom, G.H. Bol, T. Willigenburg, A.M. Werensteijn-Honingh, I.M. Jürgenliemk-Schulz, A.L.H.M.W. van Lier, P.S. Kroon. Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy. Physics and Imaging in Radiation Oncology (2021). DOI: 10.1016/j.phro.2021.11.002. 7. F.R. Teunissen, R.C. Wortel, J. Hes, T. Willigenburg, E.N. de Groot-van Breugel, J.C.J. de Boer, H.E. van Melick, H.M. Verkooijen, J.R.N. van der Voort van Zyp. Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients. Physics and Imaging in Radiation Oncology (2021). DOI: 10.1016/j.phro.2021.09.002. 8. D.M. de Muinck Keizer, T. Willigenburg, J.R.N. van der Voort van Zyp, B.W.. Raaymakers, J.J.W. Lagendijk, J.C.J. de Boer. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac. Radiotherapy and Oncology (2021). DOI: 10.1016/j.radonc.2021.07.014. 9. T. Willigenburg, M.J. van Son, S.M.G. van de Pol, W.S.C. Eppinga, J.J.W. Lagendijk, J.C.J. de Boer, M.A. Moerland, M. Peters, J.R.N. van der Voort van Zyp. Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer. Clinical and Translational Radiation Oncology (2021). DOI: 10.1016/j.ctro.2021.06.005. A
RkJQdWJsaXNoZXIy MTk4NDMw